Press Releases Archive
2021
Healing with resistance-breaking molecules from Regensburg
(No. 254) Lysando AG in BioPark Regensburg and AiCuris AG, a spin-off from Bayer AG, have started a new joint project for the treatment of chronic wounds, such as those of the diabetic foot. With a completely new class of molecules, antibiotic resistance is to be broken through and new treatment options made possible.
read on
Innovative therapeutic approach with nanocarriers
(No. 253) BioPark Regensburg GmbH, a company of the City of Regensburg, and the patent law firm Dehmel & Bettenhausen based there have awarded this year's innovation prize for an outstanding doctoral thesis at the University of Regensburg. The thesis describes a novel strategy for the treatment of diabetic nephropathy with the aid of nanocarriers.
read on
Regensburg clusters bundle AI expertise in the goAIR project
(No. 252) Four industry clusters are located in both the technology and start-up centers of the City of Regensburg-BioPark and TechBase, which for the first time have launched a cross-network initiative in the field of artificial intelligence (AI). The cross-cluster project, in which the Bioregion Regensburg is involved, was convincing at the federal level and is being funded for 1 year with funds from the “go-cluster” program.
read on
Hygiene Innovation Day 2021 in the Regensburg Jahnstadion
(No. 251) What have we learned about hygiene from the Corona pandemic in the last two years? Which measures and means reduce the pathogen load in the medical environment? The Hygiene Innovation Day 2021 in Regensburg investigated these questions, presented the latest research results and product developments and discussed various approaches to improving hygiene.
read on
lifespin supports the startup scene at Harvard University in the United States
(No. 250) The company lifespin GmbH from BioPark Regensburg is a founding member of the Wyss Diagnostics Accelerator Program in the Industrial Participant Program at the renowned Harvard University in Cambridge in the USA. The program supports the development of breakthrough diagnostic technologies to improve disease screening management.
read onARCHIVE